Navigation Links
Biochemist unlocks gene's role in breast-tumor growth
Date:4/30/2010

This release is available in French.

New research led by McGill Biochemist Dr. William Muller helps explain why breast-milk cells lose their structure, causing them to clump up in strange ways (photos available) and sometimes become cancer tumors. With the support of Chen Ling and Dongmei Zuo at McGill's Goodman Cancer Centre, Muller has discovered how one particular gene regulates epithelial cells cells that normally form in sheets and are polarized to enable the transport of molecules in a single direction. It's this loss of polarity that is thought to play an important role in breast tumor development. Scientists at the Ontario Cancer Institute (Princess Margaret Hospital's research arm) and Cold Spring Harbor Laboratory in New York State also contributed to the findings.

By using mouse models, Muller discovered that the cells do not form neat structures when the gene malfunctions. "In fact, the first mouse model had a skin defect and was completely incapable of forming sheets of epithelial cells. This gene is frequently lost in breast cancer, significant proof that this gene might play an important role," he said.

The research published today in Genes and Development shows that if the gene is reintroduced into a tumour, polarity can be restored. "This is an interesting first step along this particular path," Muller said, pointing out that the gene functions by working with more than 40 various proteins, of which only one, a scaffold protein, has been identified. Proteins, he said, play various roles in our body, from maintaining cell shape and function through to driving chemical reactions, immune responses and growth.

"We have many other steps to take before we can say this path will lead to a treatment or cure."


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert  

Page: 1

Related biology news :

1. Biochemist researching computer models of protein structure that help high school, college students
2. Stimulus funding helps K-State biochemist study eyes lens in diabetes, galactosemia patients
3. Springer partners with the American Society for Biochemistry and Molecular Biology
4. ASBMB Annual Meeting to feature talks on the biochemistry of aging
5. UC Riverside biochemist to study how crops can increase protein production
6. Phytoplankton cell membranes challenge fundamentals of biochemistry
7. Biochemistry of human physiology in health and disease is focus of updated clinical text
8. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
9. UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants
10. Computational biochemist uncovers a molecular clue to evolution
11. Biochemists manipulate fruit flavor enzymes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biochemist unlocks gene's role in breast-tumor growth
(Date:2/3/2016)... , February 3, 2016 ... new market research report "Automated Fingerprint Identification System Market ... Latent Search), Application (Banking & Finance, Government, Healthcare, and ... by MarketsandMarkets, the market is expected to be worth ... of 21.0% between 2015 and 2020. The transformation and ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first ... (AHA) announced plans to develop a first of its ... power of IBM Watson. In the first application of ... IBM (NYSE: IBM ), and Welltok will create ... health assessments with cognitive analytics, delivered on Welltok,s health ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  Spherix Incorporated (Nasdaq: SPEX ... and monetization of intellectual property, today provided an update ... the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings that ... The IPR was initiated on only certain claims of ...
(Date:2/4/2016)... ... February 04, 2016 , ... Many of the engineers at ... years. What sets them apart from other cuvette manufacturers is their supercharged customer ... website. On top of this steady flow of inside information, they have recently ...
(Date:2/3/2016)... , Feb. 3, 2016 Ascendis Pharma A/S ... that applies its innovative TransCon technology to address significant ... an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare Conference ... , Wednesday, February 10, 2016 Time:  , 11:55am ... . --> An audio webcast of this ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences is currently in ... to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company ... , Following on from the first misfolded Amyloid beta target announced on Nov. ...
Breaking Biology Technology: